Effect of Race on Biochemical Disease-free Outcome in Patients with Prostate Cancer Treated with Definitive Radiation Therapy in an Equal-Access Health Care System: Radiation Oncology Report of the Department of Defense Center for Prostate Disease Research
Peter A.S. Johnstone(Moffitt Cancer Center), Christopher L. Amling(Oregon Health & Science University), Christopher J. Kane(University of California San Diego), Timothy F. Donahue(Memorial Sloan Kettering Cancer Center), Judd W. Moul(General Marble (Greece)), Leon Sun(Madigan Army Medical Center), Jason Do(Naval Medical Center San Diego), John B. Foley(Naval Medical Center San Diego), Leo Kusuda(Madigan Army Medical Center), Douglas Martin(Naval Medical Center San Diego), Michael G. Beat(Naval Medical Center San Diego), Hongyu Wu(Qingdao University), Raymond Lance(Madigan Army Medical Center), David G. McLeod(George Washington University), Robert G. Douglas(Naval Medical Center San Diego), Dalton Baldwin(Malcolm Grow Medical Clinic), Douglas W. Soderdahl(Eisenhower Medical Center)
Cited by 39
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656